Morphine

Generic Name
Morphine
Brand Names
Arymo, Avinza, Doloral, Duramorph, Embeda, Infumorph, Kadian, M-ediat, M-eslon, MSIR, Mitigo, Ms Contin, Statex
Drug Type
Small Molecule
Chemical Formula
C17H19NO3
CAS Number
57-27-2
Unique Ingredient Identifier
76I7G6D29C
Background

Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorp...

Indication

Morphine is used for the management of chronic, moderate to severe pain.

Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.

Associated Conditions
Chronic Pain, Severe Pain
Associated Therapies
-

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

First Posted Date
2024-05-13
Last Posted Date
2024-10-08
Lead Sponsor
Peking University First Hospital
Target Recruit Count
252
Registration Number
NCT06411665
Locations
🇨🇳

Dong-Xin Wang, Beijing, China

Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study

First Posted Date
2024-05-10
Last Posted Date
2024-05-17
Lead Sponsor
Tongji Hospital
Target Recruit Count
80
Registration Number
NCT06409689

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery

Early Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-04-29
Last Posted Date
2024-08-09
Lead Sponsor
University of Virginia
Target Recruit Count
40
Registration Number
NCT06387303
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section

First Posted Date
2024-04-03
Last Posted Date
2024-04-22
Lead Sponsor
Dalin Tzu Chi General Hospital
Target Recruit Count
120
Registration Number
NCT06344169

Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery

First Posted Date
2024-03-25
Last Posted Date
2024-05-14
Lead Sponsor
Boston Children's Hospital
Target Recruit Count
58
Registration Number
NCT06326983
Locations
🇺🇸

Boston Children's Hospital, Waltham, Massachusetts, United States

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2024-03-20
Last Posted Date
2024-07-23
Lead Sponsor
Cairo University
Target Recruit Count
50
Registration Number
NCT06319859
Locations
🇪🇬

Kasr Alaini hospital, Cairo, Egypt

Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Phase 3
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-03-18
Last Posted Date
2024-03-18
Lead Sponsor
Oman Medical Speciality Board
Target Recruit Count
226
Registration Number
NCT06315920

Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions

First Posted Date
2024-01-05
Last Posted Date
2024-04-12
Lead Sponsor
Food and Drug Administration (FDA)
Target Recruit Count
240
Registration Number
NCT06192589
Locations
🇺🇸

Spaulding Clinical Research, West Bend, Wisconsin, United States

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2023-12-29
Last Posted Date
2024-03-25
Lead Sponsor
Murdoch Childrens Research Institute
Target Recruit Count
690
Registration Number
NCT06186141
Locations
🇦🇺

The Royal Children's Hospital, Melbourne, Victoria, Australia

© Copyright 2024. All Rights Reserved by MedPath